Such speculation was supported by our data, which showed that the expression of E-cadherin paralleled the expression of DACH1 (Figures 1e and f) and that DACH1-mediated enhanced transcription of E-cadherin in breast cancer cells ultimately led to the inhibition of EMT in these cells (Figure 3). Here, DACH1 is linked to breast cancer.